Biomarkers – Multimedia

This application note presents the latest electrophoretic solutions for a more rapid assessment of cfDNA samples and optimal biomarker discovery.

By taking a multidisciplinary approach that integrates engineering, electronics and nanotechnology with state-of-the-art chemistry and molecular diagnostics tools, we are entering a new phase of personalized medicine. Download this listicle to learn more about the four top trends in personalized medicine.

To accelerate the discovery of new cancer biomarkers and new insights into the genetics of treatment-resistant tumors, it is crucial to gain a deeper understanding of the genomic and epigenomic variations in cancer.

Through a selection of articles, interviews and graphics, this eBook will provide readers with an overview of key advances in proteomics technologies and the applications of proteomics research.

This app note highlights a highly sensitive method developed for the detection of GalSPH and GluSPH in CSF.

This episode provides an overview of spatial biology and what applications scientists can pursue by exploring this area.

According to the World Health Organization (WHO), cancer is a leading cause of death worldwide. Furthermore, recent estimates predict that as many as one in two people could develop a form of cancer in their lifetime.

Bile acids are well known for their roles in cholesterol homeostasis, lipid absorption and as metabolic signaling molecules. They are implicated in a variety of disease states and therefore serve as an exciting focus on research in novel biomarker discovery.

With unparalleled speed, sensitivity and spatial resolution, Shimadzu’s iMScope QT imaging mass microscope clears the way to next-generation mass spectrometry imaging in areas such as biomarker tracking, pharmacokinetics, and ADME studies.

Get to market faster with LuminexPLORE Lab custom assay development and multiplex testing services. Our team of scientists combine technical precision with industry-leading xMAP® and xTAG® technologies to produce highly specific proteomic and genomic multiplex assays.